Numerous studies have highlighted the negative clinical implications of aberrant HLA-E expression by various solid cancers, hinting towards the possible immunosuppression of HLA-I-independent recognition and killing by tumour-infiltrating NK cells [81,82,83,84]. This evidence concerns the gene HLA-E and neoplasm.